Crossref
Anticancer Effects of Nervonic Acid in Triple-Negative Breast Cancer
Journal of Oleo Science · 2025
DOI: 10.5650/jos.ess24342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oleo Science, 2025. Verfasst von Akiho Kawai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Agricultural and Life Science, Kindai University. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Triple Negative Breast NeoplasmsAntineoplastic AgentsAnimalsFemaleMice, Inbred BALB CCell Line, TumorApoptosisHumansMatrix Metalloproteinase 9Mice, NudeCell ProliferationNF-kappa BCell SurvivalCell MovementDose-Response Relationship, DrugMiceCadherinsMatrix Metalloproteinase 2Ki-67 AntigenFatty Acids, Monounsaturated
Stichwörter der Autor:innen
TNBCanticancer drugapoptosisnervonic acidtriple-negative breast cancer
Substanzen
Matrix Metalloproteinase 9Antineoplastic Agentsnervonic acidNF-kappa BCadherinsMatrix Metalloproteinase 2Ki-67 AntigenFatty Acids, Monounsaturated
Autor:innen und Institutionen
- Graduate School of Agricultural and Life Science, Kindai University.
- Department of Diagnostic Pathology, Kindai University Hospital.
- Department of Food Science and Nutrition, Kindai University.
- Anti-Aging Center, Kindai University.
Zitieren
APA
Kawai, A., Ono, F., Satou, T., & Itoh, T. (2025). Anticancer Effects of Nervonic Acid in Triple-Negative Breast Cancer. Journal of Oleo Science. https://doi.org/10.5650/jos.ess24342
Vancouver
Kawai A, Ono F, Satou T, Itoh T. Anticancer Effects of Nervonic Acid in Triple-Negative Breast Cancer. Journal of Oleo Science. 2025. doi:10.5650/jos.ess24342
BibTeX
@article{Kawai2025,
author = {Kawai, Akiho and Ono, Fumiaki and Satou, Takao and Itoh, Tatsuki},
title = {Anticancer Effects of Nervonic Acid in Triple-Negative Breast Cancer},
journal = {Journal of Oleo Science},
year = {2025},
doi = {10.5650/jos.ess24342}
}
EUVIMED